Guardant Health Q3'26 Earnings Preview: EPS Estimate at (0.75) USD
Guardant Health is scheduled to report Q3'26 results on November 5 after market close. Revenue is estimated at 350.72 million USD, with EPS anticipated at (0.75) USD.
Related stories
Array Technologies to Merge With Shoals in an All-Stock Deal
Array Technologies and Shoals will combine in an all-stock transaction.
M impact | EQUITY | Nov 04, 2026, 02:21 PM UTC
Enviri Exits Deutsche Bahn Contract, Expects $19 Million Gain
Enviri released Harsco Rail from its Deutsche Bahn contract after repaying approximately $73 million in advances. The company expects a net gain of approximately $19 million with t
M impact | EQUITY | Nov 04, 2026, 02:09 PM UTC
Solstice Raises Annual Outlook as AI Demand Drives Quarterly Results Above Expectations
Solstice raised its annual forecasts, citing AI-related demand and quarterly results above expectations.
M impact | EQUITY | Nov 04, 2026, 02:09 PM UTC
Alphabet Backs TeraWulf Credit for Anthropic Data Center Project
TeraWulf receives credit backing from Alphabet for its data center project for Anthropic.
M impact | EQUITY | Nov 04, 2026, 02:08 PM UTC
Vivakor Highlights Potential Annual Service Revenue Above $2 Million
Direct Midstream’s conditional agreement to operate 52 New Mexico wells could generate more than $2 million in annual service revenue at targeted operating levels, subject to final
M impact | EQUITY | Nov 04, 2026, 02:08 PM UTC
TeraWulf Gets Google Credit Backing for Anthropic Data Center Project
M impact | EQUITY | Nov 04, 2026, 02:08 PM UTC